Medco Health Solutions said it has acquired DNA Direct, a genomic-medicine consulting company, for an undisclosed sum.
Based in San Francisco, DNA Direct offers guidance to providers, payers and employers on more than 2,000 genetic and molecular tests on the market today. Clients include Humana and 298-bed El Camino Hospital in Mountain View, Calif. Medco officials said they would integrate DNA Direct's services with Medco's personalized medicine portfolio, with an aim to deliver more precision health services. The Franklin Lakes, N.J.-based company is a leading pharmacy benefits manager.
“By integrating proven state-of-the-art science into everyday care, we are providing patients and providers with actionable information that drives more personalized care to achieve higher efficacy or improved safety,” said Robert Epstein, chief medical officer of Medco, in a written statement.
Ryan Phelan, founder and CEO of DNA Direct, said in a written statement that he “can't think of a better partner to take personalized medicine to the next level.” (For more on personalized medicine, please see Rebecca Vesely's Biotechnology advances help drive '09 investments. Also sign up for our Webcast: Fulfilling the promise of biotechnology set for Feb. 10.)